Controlled Clinical Trials in Neurological Disease.
[Book]
Porter, Roger J.; Schoenberg, Bruce S.
Springer Verlag
2011
I. Design of Controlled Clinical Trials.- 1. Clinical considerations.- 2. Initial statistical considerations.- 3. Statistical and epidemiological considerations.- II. Implementation and Interpretations of Controlled Clinical Trials (Example: Epilepsy).- 4. Perspective of the patient.- 5. Perspective of the participating investigator.- 6. Perspective of the clinical center.- 7. Perspective of the coordinating center.- 8. Perspective of the food and drug administration.- 9. Perspective of the pharmaceutical industry.- 10. Perspective of the insurance industry.- III. Applications of Controlled Clinical Trials to Diseases of the Nervous System.- 11. Cerebrovascular disease.- 12. Epilepsy.- 13. Movement disorders.- 14. Head and spinal cord injury.- 15. Headache.- 16. Peripheral neuropathy.- 17. Guillain-Barre: Plasmapheresis.- 18. Motor neuron disease.- 19. Myasthenia gravis.- 20. Muscular dystrophy.- 21. Multiple sclerosis.- 22. Brain tumors.- 23. Alzheimer's disease.- 24. Viral diseases: Herpes simplex encephalitis.- 25. Parasitic diseases.